This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hauser, U.
Right arrow Articles by Wilske, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hauser, U.
Right arrow Articles by Wilske, B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 1999, p. 2241-2247, Vol. 37, No. 7
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Validity of Interpretation Criteria for Standardized Western Blots (Immunoblots) for Serodiagnosis of Lyme Borreliosis Based on Sera Collected throughout Europe

Ulrike Hauser, Gisela Lehnert, and Bettina Wilske*

Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie der Ludwig-Maximilians-Universität München, D-80336 Munich, Germany

Received 23 November 1998/Returned for modification 8 March 1999/Accepted 6 April 1999

Western blotting (WB; immunoblotting) is a widely used tool for the serodiagnosis of Lyme borreliosis (LB), but so far, no generally accepted criteria for performance and interpretation have been established in Europe. The current study was preceeded by a detailed analysis of WB with whole-cell lysates of three species of Borrelia burgdorferi sensu lato (U. Hauser, G. Lehnert, R. Lobentanzer, and B. Wilske, J. Clin. Microbiol. 35:1433-1444, 1997). In that study, interpretation criteria for a positive WB result were developed with the data for 330 serum samples (from patients with LB in different stages [n = 189] and from a control group [n = 141]) originating mostly from southern Germany. In the present work, the interpretation criteria for strains PKo (Borrelia afzelii) and PBi (Borrelia garinii) developed in the previous study were reevaluated with 224 serum samples (from patients with LB in different stages [n = 97] and from a control group [n = 127]) originating from throughout Europe that were provided by the European Union Concerted Action on Lyme Borreliosis (EUCALB). De novo criteria were developed on the basis of the reactivities of the EUCALB sera and were evaluated with the data for the samples from southern Germany. Comparison of all results led to the following recommendations: For WB for immunoglobulin G (IgG), at least two bands among p83/100, p58, p43, p39, p30, OspC, p21, p17, and p14 for PKo and at least one band among p83/100, p39, p30, OspC, p21, and p17b for PBi; for WB for IgM, at least one band among p39, OspC, and p17 or a strong p41 band for PKo and at least one band among p39 and OspC or a strong p41 band for PBi. WB with PKo was the most sensitive, and this strain is recommended for use in WB for the serodiagnosis of LB throughout Europe.

* Corresponding author. Mailing address: Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie der Ludwig-Maximilians-Universität München, Pettenkoferstrasse 9a, D-80336 München, Germany. Phone: 0049-89-51605231. Fax: 0049-89-51604757. E-mail: Bettina.Wilske{at}mvp-bak.med.uni-muenchen.de.

Journal of Clinical Microbiology, July 1999, p. 2241-2247, Vol. 37, No. 7
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Siegel, C., Schreiber, J., Haupt, K., Skerka, C., Brade, V., Simon, M. M., Stevenson, B., Wallich, R., Zipfel, P. F., Kraiczy, P. (2008). Deciphering the Ligand-binding Sites in the Borrelia burgdorferi Complement Regulator-acquiring Surface Protein 2 Required for Interactions with the Human Immune Regulators Factor H and Factor H-like Protein 1. J. Biol. Chem. 283: 34855-34863 [Abstract] [Full Text]  
  • Herzberger, P., Siegel, C., Skerka, C., Fingerle, V., Schulte-Spechtel, U., van Dam, A., Wilske, B., Brade, V., Zipfel, P. F., Wallich, R., Kraiczy, P. (2007). Human Pathogenic Borrelia spielmanii sp. nov. Resists Complement-Mediated Killing by Direct Binding of Immune Regulators Factor H and Factor H-Like Protein 1. Infect. Immun. 75: 4817-4825 [Abstract] [Full Text]  
  • Marangoni, A., Sambri, V., Accardo, S., Cavrini, F., Mondardini, V., Moroni, A., Storni, E., Cevenini, R. (2006). A Decrease in the Immunoglobulin G Antibody Response against the VlsE Protein of Borrelia burgdorferi Sensu Lato Correlates with the Resolution of Clinical Signs in Antibiotic-Treated Patients with Early Lyme Disease. CVI 13: 525-529 [Abstract] [Full Text]  
  • Marangoni, A., Sparacino, M., Cavrini, F., Storni, E., Mondardini, V., Sambri, V., Cevenini, R. (2005). Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy. J Med Microbiol 54: 361-367 [Abstract] [Full Text]  
  • Houpikian, P., Raoult, D. (2003). Western Immunoblotting for Bartonella Endocarditis. CVI 10: 95-102 [Abstract] [Full Text]  
  • Ornstein, K., Ostberg, Y., Bunikis, J., Noppa, L., Berglund, J., Norrby, R., Bergstrom, S. (2002). Differential Immune Response to the Variable Surface Loop Antigen of P66 of Borrelia burgdorferi Sensu Lato Species in Geographically Diverse Populations of Lyme Borreliosis Patients. CVI 9: 1382-1384 [Abstract] [Full Text]  
  • Liang, F. T., Nelson, F. K., Fikrig, E. (2002). DNA Microarray Assessment of Putative Borrelia burgdorferi Lipoprotein Genes. Infect. Immun. 70: 3300-3303 [Abstract] [Full Text]  
  • Heikkila, T., Seppala, I., Saxen, H., Panelius, J., Yrjanainen, H., Lahdenne, P. (2002). Species-Specific Serodiagnosis of Lyme Arthritis and Neuroborreliosis Due to Borrelia burgdorferi Sensu Stricto, B. afzelii, and B. garinii by Using Decorin Binding Protein A. J. Clin. Microbiol. 40: 453-460 [Abstract] [Full Text]  
  • Robertson, J., Guy, E., Andrews, N., Wilske, B., Anda, P., Granström, M., Hauser, U., Moosmann, Y., Sambri, V., Schellekens, J., Stanek, G., Gray, J. (2000). A European Multicenter Study of Immunoblotting in Serodiagnosis of Lyme Borreliosis. J. Clin. Microbiol. 38: 2097-2102 [Abstract] [Full Text]  
  • Miller, J. C., El-Hage, N., Babb, K., Stevenson, B. (2000). Borrelia burgdorferi B31 Erp Proteins That Are Dominant Immunoblot Antigens of Animals Infected with Isolate B31 Are Recognized by Only a Subset of Human Lyme Disease Patient Sera. J. Clin. Microbiol. 38: 1569-1574 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»